Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Cholestatic Pruritus

Immunology

Immunology Today—March 25, 2026

This week’s Immunology update highlights regulatory progress, dermatology…

Rare Disease news

Rare Diseases Today—March 19, 2026

This week’s Rare Diseases update highlights regulatory momentum, clinical…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Immunology Today—May 6, 2026
Neuroscience Today—May 6, 2026
Lucid Diligence Brief: Arrowhead ARO-PNPLA3 licensed to Madrigal
Obesity Today—May 5, 2026
Endocrinology Today—May 5, 2026

Tags

AAV MYO2 ABO2203 ART5803 B7-H3 CanSino cardiovascular risk factors CartiLife Cas12 Chronic Limb-Threatening Ischemia Corcept cutaneous T-cell lymphoma cytomegalovirus Dapagliflozin data linkage Dexcom EAACI Epitopea Evkeeza FSHD Galen AI Global Burden of Disease Hanmi HM17321 heart failure congestion Heart Transplant Rejection IL1RAP Kisunla LTI-03 MannKind Miltenyi Bioindustry multispecific antibodies Nature Immunology neurological epidemiology Oncolytics Biotech PANTHERx Rare personalized cancer vaccine Redx Pharma risperidone LAI Saudi Arabia SetPoint Medical Systemic lupus erythematosus TYK2 inhibitor UnitedHealthcare UZEDY WINREVAIR Yashoda

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Immunology Today—May 6, 2026
Neuroscience Today—May 6, 2026
Lucid Diligence Brief: Arrowhead ARO-PNPLA3 licensed to Madrigal
Obesity Today—May 5, 2026
Endocrinology Today—May 5, 2026

TAGS

AAV MYO2 ABO2203 ART5803 B7-H3 CanSino cardiovascular risk factors CartiLife Cas12 Chronic Limb-Threatening Ischemia Corcept cutaneous T-cell lymphoma cytomegalovirus Dapagliflozin data linkage Dexcom EAACI Epitopea Evkeeza FSHD Galen AI Global Burden of Disease Hanmi HM17321 heart failure congestion Heart Transplant Rejection IL1RAP Kisunla LTI-03 MannKind Miltenyi Bioindustry multispecific antibodies Nature Immunology neurological epidemiology Oncolytics Biotech PANTHERx Rare personalized cancer vaccine Redx Pharma risperidone LAI Saudi Arabia SetPoint Medical Systemic lupus erythematosus TYK2 inhibitor UnitedHealthcare UZEDY WINREVAIR Yashoda

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy